Urovant Sciences Ltd. — key financial figures for fiscal year 2019 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2019)

-$146.7M

Total Assets (FY2019)

$63.3M

Total Equity (FY2019)

-$58.0M

Cash Flows from Operating Activities (FY2019)

-$102.1M

Source: Urovant Sciences Ltd. 10-K filing (FY2019). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.